3.40
price down icon1.73%   -0.06
after-market After Hours: 3.40
loading
Mural Oncology Plc stock is traded at $3.40, with a volume of 58,947. It is down -1.73% in the last 24 hours and up +1.19% over the past month. Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.
See More
Previous Close:
$3.46
Open:
$3.45
24h Volume:
58,947
Relative Volume:
0.69
Market Cap:
$58.78M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-6.34%
1M Performance:
+1.19%
6M Performance:
-11.23%
1Y Performance:
+0.00%
1-Day Range:
Value
$3.25
$3.53
1-Week Range:
Value
$3.25
$3.6458
52-Week Range:
Value
$2.88
$6.00

Mural Oncology Plc Stock (MURA) Company Profile

Name
Name
Mural Oncology Plc
Name
Phone
353 1 905 8020
Name
Address
10 EARLSFORT TERRACE, DUBLIN 2
Name
Employee
107
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
MURA's Discussions on Twitter

Mural Oncology Plc Stock (MURA) Latest News

pulisher
04:24 AM

Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

04:24 AM
pulisher
Nov 01, 2024

Mural Oncology CFO Adam Cutler sells $25,305 in company stock By Investing.com - Investing.com Canada

Nov 01, 2024
pulisher
Nov 01, 2024

Mural Oncology plc (NASDAQ:MURA) CFO Adam D. Cutler Sells 7,421 Shares - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Mural Oncology CFO Adam Cutler sells $25,305 in company stock - Investing.com

Nov 01, 2024
pulisher
Oct 28, 2024

Short Interest in Mural Oncology plc (NASDAQ:MURA) Decreases By 15.7% - MarketBeat

Oct 28, 2024
pulisher
Oct 21, 2024

HC Wainwright Comments on Mural Oncology Q3 Earnings - MarketBeat

Oct 21, 2024
pulisher
Oct 17, 2024

Mural Oncology (NASDAQ:MURA) Coverage Initiated at HC Wainwright - MarketBeat

Oct 17, 2024
pulisher
Oct 17, 2024

HC Wainwright & Co. Initiates Coverage of Mural Oncology (MURA) with Buy Recommendation - MSN

Oct 17, 2024
pulisher
Oct 10, 2024

167,644 Shares in Mural Oncology plc (NASDAQ:MURA) Bought by Squarepoint Ops LLC - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

232,100 Shares in Mural Oncology plc (NASDAQ:MURA) Bought by Renaissance Technologies LLC - MarketBeat

Oct 09, 2024
pulisher
Oct 07, 2024

Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - The Manila Times

Oct 07, 2024
pulisher
Oct 04, 2024

Raymond James Begins Coverage on Mural Oncology (NASDAQ:MURA) - Defense World

Oct 04, 2024
pulisher
Oct 04, 2024

Mural Oncology (NASDAQ:MURA) Coverage Initiated by Analysts at Raymond James - MarketBeat

Oct 04, 2024
pulisher
Oct 02, 2024

Rhumbline Advisers Makes New $34,000 Investment in Mural Oncology plc (NASDAQ:MURA) - Defense World

Oct 02, 2024
pulisher
Oct 01, 2024

Point72 Asia Singapore Pte. Ltd. Invests $84,000 in Mural Oncology plc (NASDAQ:MURA) - Defense World

Oct 01, 2024
pulisher
Sep 30, 2024

Mural Oncology Highlights Clinical Trials During It's Maiden Investor Day - Forbes

Sep 30, 2024
pulisher
Sep 28, 2024

Armistice Capital LLC Takes Position in Mural Oncology plc (NASDAQ:MURA) - Defense World

Sep 28, 2024
pulisher
Sep 27, 2024

1,688,000 Shares in Mural Oncology plc (NASDAQ:MURA) Acquired by Armistice Capital LLC - MarketBeat

Sep 27, 2024
pulisher
Sep 26, 2024

Mural Oncology's First Virtual Investor Day to Highlight Late-Stage Clinical Progress - The Manila Times

Sep 26, 2024
pulisher
Sep 26, 2024

Mural Oncology’s First Virtual Investor Day to Highlight Late-Stage Clinical Progress - StockTitan

Sep 26, 2024
pulisher
Sep 23, 2024

Mural Oncology appoints new board member amid growth phase - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

Mural Oncology appoints new director and audit chair - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

Mural Oncology appoints new director and audit chair By Investing.com - Investing.com UK

Sep 23, 2024
pulisher
Sep 23, 2024

Mural Oncology Appoints Sachiyo Minegishi To Board - citybiz

Sep 23, 2024
pulisher
Sep 23, 2024

Mural Oncology Strengthens Board of Directors with the Appointment of Sachiyo Minegishi - EIN News

Sep 23, 2024
pulisher
Sep 23, 2024

Mural Oncology appoints new board member amid growth phase By Investing.com - Investing.com South Africa

Sep 23, 2024
pulisher
Sep 20, 2024

Primecap Management Co. CA Purchases Shares of 235,551 Mural Oncology plc (NASDAQ:MURA) - MarketBeat

Sep 20, 2024
pulisher
Sep 19, 2024

Primecap Management Co. CA Buys New Holdings in Mural Oncology plc (NASDAQ:MURA) - Defense World

Sep 19, 2024
pulisher
Sep 17, 2024

Acadian Asset Management LLC Takes $998,000 Position in Mural Oncology plc (NASDAQ:MURA) - MarketBeat

Sep 17, 2024
pulisher
Sep 17, 2024

Acadian Asset Management LLC Buys Shares of 318,536 Mural Oncology plc (NASDAQ:MURA) - Defense World

Sep 17, 2024
pulisher
Sep 10, 2024

Mural Oncology to Host First Virtual Investor Day on September 26, 2024 - ForexTV.com

Sep 10, 2024
pulisher
Sep 04, 2024

We Think Mural Oncology (NASDAQ:MURA) Needs To Drive Business Growth Carefully - Yahoo Finance

Sep 04, 2024
pulisher
Aug 27, 2024

MURAMural Oncology plc Ordinary Shares Latest Stock News & Market Updates - StockTitan

Aug 27, 2024
pulisher
Aug 27, 2024

Mural Oncology to Present at Two Upcoming Investor Conferences - ForexTV.com

Aug 27, 2024
pulisher
Aug 14, 2024

Mural Oncology plc (NASDAQ:MURA) Sees Significant Decrease in Short Interest - MarketBeat

Aug 14, 2024
pulisher
Aug 14, 2024

Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress - BioSpace

Aug 14, 2024
pulisher
Aug 09, 2024

Harbor Capital Advisors Inc. Takes Position in Mural Oncology plc (NASDAQ:MURA) - Defense World

Aug 09, 2024
pulisher
Aug 03, 2024

Critical Analysis: Mural Oncology (NASDAQ:MURA) & Kamada (NASDAQ:KMDA) - Defense World

Aug 03, 2024
pulisher
Jul 31, 2024

Mural Oncology Appoints George Golumbeski, Ph.D., to its Board of Directors - citybiz

Jul 31, 2024
pulisher
Jul 31, 2024

Mural Oncology appoints new independent director By Investing.com - Investing.com Nigeria

Jul 31, 2024
pulisher
Jul 31, 2024

Mural Oncology appoints George Golumbeski to board - Investing.com

Jul 31, 2024
pulisher
Jul 31, 2024

Mural Oncology appoints new independent director - Investing.com India

Jul 31, 2024
pulisher
Jul 31, 2024

Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors - ForexTV.com

Jul 31, 2024
pulisher
Jul 29, 2024

Head to Head Survey: Mural Oncology (NASDAQ:MURA) and Mereo BioPharma Group (NASDAQ:MREO) - Defense World

Jul 29, 2024
pulisher
Jul 13, 2024

Mural Oncology plc (NASDAQ:MURA) Short Interest Down 18.4% in June - Defense World

Jul 13, 2024
pulisher
Jul 13, 2024

Short Interest in Mural Oncology plc (NASDAQ:MURA) Declines By 18.4% - MarketBeat

Jul 13, 2024
pulisher
Jul 11, 2024

Evaluating MURA’s financial ratios for a profitable investment - US Post News

Jul 11, 2024
pulisher
Jul 09, 2024

Mural Oncology plc (NASDAQ:MURA) CEO Caroline Loew Sells 12,531 Shares of Stock - Defense World

Jul 09, 2024
pulisher
Jul 08, 2024

Mural Oncology plc (NASDAQ:MURA) CEO Caroline Loew Sells 12,531 Shares - MarketBeat

Jul 08, 2024
pulisher
Jul 03, 2024

Mural Oncology reports inducement grants under Nasdaq listing rule - Medical Buyer

Jul 03, 2024

Mural Oncology Plc Stock (MURA) Financials Data

There is no financial data for Mural Oncology Plc (MURA). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$19.96
price up icon 5.11%
$75.75
price down icon 0.50%
$376.80
price up icon 0.74%
$53.54
price down icon 2.00%
$207.25
price up icon 1.49%
$108.97
price down icon 2.25%
Cap:     |  Volume (24h):